Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-01

Clinical Trial Update: Omega-3 Fatty Acids in Tourette's Disorder [NA]

View source ↗

Summary

This entry notes a completed clinical trial evaluating omega-3 fatty acids for Tourette syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: NYU Langone Health | Conditions: Tourette's Disorder | NA | Status: COMPLETED